Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
format_facet:"Elektronische Ressource"
collection:"CTG"
topic_facet:"Medical Condition: Primary IgA Nephropathy MedDRA version: 20.0Level: HLGTClassification code 10029149Term: NephropathiesSystem Organ Class: 10038359 - Renal and urinary disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Primary+IgA+Nephropathy+MedDRA+version%3A+20.0Level%3A+HLGTClassification+code+10029149Term%3A+NephropathiesSystem+Organ+Class%3A+10038359+-+Renal+and+urinary+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Immune+System+Diseases+%5BC20%5D%22&lookfor=%22IgA%22&type=Subject
/vufind/Search/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Primary+IgA+Nephropathy+MedDRA+version%3A+20.0Level%3A+HLGTClassification+code+10029149Term%3A+NephropathiesSystem+Organ+Class%3A+10038359+-+Renal+and+urinary+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Immune+System+Diseases+%5BC20%5D%22&lookfor=%22IgA%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=format_facet%3A%22Elektronische+Ressource%22&filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Primary+IgA+Nephropathy+MedDRA+version%3A+20.0Level%3A+HLGTClassification+code+10029149Term%3A+NephropathiesSystem+Organ+Class%3A+10038359+-+Renal+and+urinary+disorders%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Immune+System+Diseases+%5BC20%5D%22&lookfor=%22IgA%22&type=Subject
PubPharm (22)
1
A study evaluating the of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
2
A study evaluating the of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
3
A study evaluating the of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
A study evaluating the of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
5
A study evaluating the of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
A study evaluating the of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
Study of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
8
Study of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
9
A study evaluating the of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
10
A study evaluating the of safety and efficacy of LNP023 in patients with a kidney disorder called IgAN nephropathy : An adaptive seamless randomized, double-blind, placebo-controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Medienart: E-Ressourcen
Filter aufheben
Thema: Medical Condition: Primary IgA Nephropathy MedDRA version: 20.0Level: HLGTClassification code 10029149Term: NephropathiesSystem Organ Class: 10038359 - Renal and urinary disorders;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
Medienart
22
Aufsätze
22
E-Artikel
E-Ressourcen
Zeitschriftentitel
22
WHO International Clinical Trials Registry Plat...
Thema
22
610
Medical Condition: Primary IgA Nephropathy MedD...
22
Phase: Phase 2
22
Study Type: Interventional
18
Recruitment Status: Not yet recruiting
4
Recruitment Status: Authorised-recruitment may ...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
18
2021
4
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
22
Englisch
Haven't found what you're looking for?
Wird geladen...